Role of interleukin 10 in murine postoperative ileus

Gut

Volumn 58, Issue 5, 2009, Pages 648-660

  Stoffels, B ^a   Schmidt, J ^a   Nakao, A ^b   Nazir, A ^a   Chanthaphavong, R S ^a   Bauer, A J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXYGENASE; PROSTAGLANDIN; PROSTANOID; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT FUNCTION; GASTROINTESTINAL TRANSIT; HISTOCHEMISTRY; ILEUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE CONTRACTION; NEUTROPHIL; NONHUMAN; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECT; JEJUNUM; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; FEMALE; GASTROINTESTINAL TRANSIT; ILEUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-10; JEJUNUM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 66349091087     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.153288     Document Type: Article

References (52)

1. Delaney CP, Wolff BG, Viscusi ER, et al. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Annals of Surgery 2007:245:355-63.
2. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil 2004:16:Suppl-60.
3. Kalff JC, Schraut WH, Billiar TR, et al. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 2001;121:1354-71.
4. Schwarz NT, Kalff JC, Turler A, et al. Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 2001:121:1354-71.
5. Turler A, Kalff JC, Moore BA, et al. Leukocyte-derived inducible nitric oxide synthase mediates murine postoperative ileus. Ann Surg 2006:244:220-9.
6. Moore BA, Otterbein LE, Turler A, et al. Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine. Gastroenterology 2005;33:1317-26.
7. Moore BA, Overhaus M, Whitcomb J, et al. Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus. Crit Care Med 2005:33:1317-26.
8. Murray PJ. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 2006:6:379-86.
9. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000:6:422-8.
10. Tamion F, Richard V, Renet S, et al. Protective effects of heme-oxygenase expression against endotoxic shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10. J Trauma 2006:61:1078-84.
11. Dinant S, Vetelainen RL, Florquin S, et al. IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 2007:141:176-82.
12. Zhou X, Schmidtke P, Zepp F, et al. Boosting interleukin-10 production: therapeutic effects and mechanisms. Curr Drug Targets Immune Endocr Metabol Disord 2005:5:465-75.
13. Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995:155:1079-90.
14. Wehinger J, Gouilleux F, Groner B, et al. IL-10 induces DNA binding activity of three STAT proteins (Stati, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 1996:394:365-70.
15. Schottelius AJ, Mayo MW, Sartor RB, et al. lnterleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999:274:31868-74.
16. Hoentjen F, Sartor RB, Ozaki M, et al. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 2005:105:689-96.
17. Nishinakamura H, Minoda Y, Saeki K, et al. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity. Int Immunol 2007:19:609-19.
18. Kontoyiannis D, Kotlyarov A, Carballo E, et al. lnterleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBOJ 2001:20:3760-70.
19. Moore KW, O'Garra A, de Waal MR, et al. lnterleukin-10. Annu Rev Immunol 1993:11:165-90.
20. Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-)) mice and intestinal inflammation. Am J Physiol 2000:278:G829-33.
21. Wehner S, Behrendt FF, Lyutenski BN, et al. Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents. Gut 2007:56:176-85.
22. Kalff JC, Schraut WH, Simmons RL, et al. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg 1998:228:652-63.
23. Kalff JC, Schwarz NT, Walgenbach KJ, et al. Leukocytes of the intestinal muscularis: their phenotype and isolation. J Leukoc Biol 1998:63:683-91.
24. Kalff JC, Buchholz BM, Eskandari MK, et al. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 1999:126:498-509.
25. Fink L, Seeger W, Ermert L, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998:4:1329-33.
26. Kosuga K, Yui Y, Hattori R, et al. Cloning of an inducible nitric oxide synthase from rat polymorphonuclear cells. Endothelium 1994:2:217-21.
27. Xu K, Robida AM, Murphy TJ. Immediate-early MEK-1 -dependent stabilization of rat smooth muscle cell cyclooxygenase-2 mRNA by Galpha(q)-coupled receptor signaling. J Biol Chem 2000:275:23012- 9.
28. Northemann W, Braciak TA, Hattori M, et al. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J Biol Chem 1989:264:16072-82.
29. Kita Y, Takashi T, ligo Y, et al. Sequence and expression of rat ICAM-1. Biochim BiophysActa 1992:1131:108-10.
30. Yoshimura T, Takeya M, Takahashi K. Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell lines. Biochem Biophys Res Commun 1991:174:504-9.
31. Tso JY, Sun XH, Kao TH, et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985:13:2485-502.
32. Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and realtime methods. Anal Biochem 2000:285:194-204.
33. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982:126:131-8.
34. Eskandari MK, Kalff JC, Billiar TR, et al. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999:277:G478-86.
35. Moore BA, Albers KM, Davis BM, et al. Altered inflammatory gene expression underlies increased susceptibility to murine postoperative ileus with advancing age. Am J Physiol 2007;292:G1650-9.
36. Kalff JC, Carlos TM, Schraut WH, et al. Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology 1999:117:378-87.
37. Kuhn R, Lohler J, Rennick D, et al. lnterleukin-10- deficient mice develop chronic enterocolitis. Cell 1993:75:263-74.
38. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993:177:547-50.
39. Howard M, Muchamuel T, Andrade S, et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993:177:1205-8.
40. Etling MR, Davies S, Campbell M, et al. Maturation of the mucosal immune system underlies colitis susceptibility in interleukin-10- defcient (IL-10-7-) mice. J Leukoc Biol 2007:82:311-9.
41. Souza DG, Guabiraba R, Pinho V, et al. IL-1-driven endogenous IL-10 production protects against the systemic and local acute inflammatory response following intestinal reperfusion injury. J Immunol 2003:170:4759-66.
42. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 2002:8:240-6.
43. Overhaus M, Moore BA, Barbato JE, et al. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol 2006:290:G695-703.
44. Li MC, He SH. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol 2004:10:620-5.
45. Ikeda T, Sato K, Kuwada N, et al. Interleukin-10 differently regulates monocyte chemoattractant protein-1 gene expression depending on the environment in a human monoblastic cell line, UG3. J Leukoc Biol 2002:72:1198-205.
46. Hickey MJ, Issekutz AC, Reinhardt PH, et al. Endogenous interleukin-10 regulates hemodynamic parameters, leukocyte-endothelial cell interactions, and microvascular permeability during endotoxemia. Circ Res 1998:83:1124-31.
47. Barbara G, Xing Z, Hogaboam CM, et al. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 2000:46:344-9.
48. The FO, Bennink RJ, Ankum WM, et al. Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut 2008:57:33-40.
49. DeGiorgio R, Barbara G. Evidence for mast cell involvement in human postoperative ileus: a novel link. Gut 2008:57:5-7.
50. Bundoc VG, Keane-Myers A. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis. Exp Eye Res 2007:85:575-9.
51. Thompson-Snipes L, Dhar V, Bond MW, et al. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991:173:507-10.
52. Ghildyal N, Friend DS, Nicodemus CF, et al. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol 1993:151:3206-14.